Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

AZ expands its mHealth services with new COPD initiative

Partners with Exco InTouch to launch Me&MyCOPD programme

AstraZeneca Me&MyCOPD Android mobile appAstraZeneca has expanded its mHealth project portfolio, with the launch of a new COPD management initiative that it will deliver in collaboration with patient engagement firm Exco InTouch.  

The Me&MyCOPD programme, which was piloted last year, uses interactive mobile phone and internet-based health tools to improve patients' management of their condition and assist their carers and healthcare providers.  

Patients enrolled on the UK programme will be offered personalised coaching and real-time information about their disease and treatment, enabling them to collect, transmit and review their own clinical data.  

Part of this will involve the mHealth programme's new Android app, which hit Google Play earlier this month and provides easy access to patients' goals and care plan, as well as healthcare advice.  

Mark Brincat, director of product strategy at Exco InTouch, said: “Me&MyCOPD will help patients to better control their condition and healthcare providers to make more informed decisions, tailoring care pathways to each patient's individual needs.  

“This translates into improving patient welfare and their quality of life by reducing the number of unplanned hospital admissions and the frequency and severity of exacerbations, decreasing the overall treatment costs at the same time.”  

COPD is one of the most common respiratory diseases in the UK and thought to affect over three million people - of which only about 900,000 have been diagnosed.  

AstraZeneca's disease management programme aims to address challenges such as improper use of medications by the patients or failing to attend clinic visits.  

The work falls within AZ's 'intelligent pharmaceuticals' strategy, under whose auspices the company earlier this year started working with Vodafone on a global mHealth partnership for cardiovascular services.

19th June 2014

From: Marketing, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics